Skip to main content

Peer Review reports

From: Exploring the potential of Gonolobus condurango as a histone deacetylase inhibitor in triple-negative breast cancer cell lines: in vitro study

Original Submission
3 Aug 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
5 Mar 2024 Reviewed Reviewer Report
8 Mar 2024 Reviewed Reviewer Report
28 Mar 2024 Reviewed Reviewer Report
12 Jun 2024 Author responded Author comments - Vajen Beate
Resubmission - Version 3
12 Jun 2024 Submitted Manuscript version 3
8 Oct 2024 Reviewed Reviewer Report
5 Dec 2024 Reviewed Reviewer Report
22 Jan 2025 Author responded Author comments - Vajen Beate
Resubmission - Version 4
22 Jan 2025 Submitted Manuscript version 4
27 Jan 2025 Author responded Author comments - Vajen Beate
Resubmission - Version 5
27 Jan 2025 Submitted Manuscript version 5
2 Feb 2025 Reviewed Reviewer Report
3 Feb 2025 Reviewed Reviewer Report
11 Feb 2025 Author responded Author comments - Vajen Beate
Resubmission - Version 6
11 Feb 2025 Submitted Manuscript version 6
18 Feb 2025 Author responded Author comments - Vajen Beate
Resubmission - Version 7
18 Feb 2025 Submitted Manuscript version 7
22 Feb 2025 Reviewed Reviewer Report
23 Feb 2025 Reviewed Reviewer Report
13 Mar 2025 Author responded Author comments - Vajen Beate
Resubmission - Version 8
13 Mar 2025 Submitted Manuscript version 8
17 Apr 2025 Author responded Author comments - Vajen Beate
Resubmission - Version 9
17 Apr 2025 Submitted Manuscript version 9
22 Apr 2025 Author responded Author comments - Vajen Beate
Resubmission - Version 10
22 Apr 2025 Submitted Manuscript version 10
Publishing
24 Apr 2025 Editorially accepted
15 May 2025 Article published 10.1186/s12906-025-04896-w

You can find further information about peer review here.

Back to article page